The boom brought bad actors
The GLP-1 telehealth market has grown explosively, and not all providers maintain the clinical standards patients deserve. The FDA has issued warning letters to multiple telehealth companies for misleading claims, and some platforms prioritize volume over safety. Knowing the red flags helps you avoid providers who cut corners.
🚩 Red Flag #1: No medical intake or health screening
If a provider prescribes GLP-1 medication without asking about your medical history, current medications, thyroid cancer history, or pancreatitis history, that is a serious safety failure. The prescribing information for both semaglutide and tirzepatide includes specific contraindications that require screening. A provider who skips this step is either negligent or running a prescription mill.
What it should look like: A comprehensive health questionnaire covering your medical history, medications, allergies, prior weight loss attempts, and screening questions for contraindications — followed by a provider review before any prescription is issued.
🚩 Red Flag #2: "Guaranteed" weight loss numbers
Any provider that promises you'll lose a specific amount of weight (e.g., "Lose 20% of your body weight guaranteed!") is violating medical ethics and likely FTC advertising guidelines. GLP-1 medications produce different results in different people — clinical trial averages are not individual guarantees. In the STEP 1 trial, while the average was 14.9%, some participants lost over 25% and others lost less than 5%.
What you should hear instead: "Based on clinical data, most patients lose 10–20% of body weight, but individual results vary based on your biology, dose, and lifestyle factors."
🚩 Red Flag #3: No information about the compounding pharmacy
If a provider offers compounded GLP-1 medications but refuses to name their compounding pharmacy, won't confirm whether it's 503A or 503B registered, or gives vague answers about quality testing, you have no way to verify what you're injecting. Reputable providers are transparent about their pharmacy partners.
What to ask: "What compounding pharmacy prepares your medications, and are they registered as a 503B outsourcing facility with the FDA?"
🚩 Red Flag #4: No prescription required or "research-grade" peptides
GLP-1 medications are prescription drugs. Any website selling them without requiring a prescription is operating illegally and likely selling unregulated products. "Research-grade" or "not for human use" peptides labeled as semaglutide are unregulated, untested, and potentially dangerous. This is not the same as compounded medication from a licensed pharmacy.
🚩 Red Flag #5: Opaque or escalating pricing
Watch for providers who advertise a low "starting" price that applies only to the lowest titration dose, charge separate membership, consultation, and lab fees not included in the quoted price, increase pricing significantly at maintenance doses without disclosing this upfront, or have confusing cancellation policies or auto-renewal terms buried in fine print.
What to verify: Ask for the total monthly cost at maintenance dose, including all fees.
🚩 Red Flag #6: No follow-up or monitoring plan
A provider that prescribes medication and then offers no structured follow-up is providing substandard care. GLP-1 treatment requires dose titration, side-effect management, and ongoing monitoring. If the answer to "how will you monitor my treatment?" is essentially "contact us if you have problems," the clinical support is inadequate.
Green flags: what good providers do
They conduct a thorough medical intake before prescribing. They screen for all contraindications listed in the prescribing information. They explain their titration approach and customize it based on your response. They name their compounding pharmacy and confirm its licensing status. They quote transparent all-in pricing at maintenance doses. They have a structured follow-up schedule, not just reactive support. And they discuss realistic expectations, including what happens when you stop the medication.